These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8018528)

  • 1. Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb.
    Klaase JM; Kroon BB; Beijnen JH; van Slooten GW; van Dongen JA
    Br J Cancer; 1994 Jul; 70(1):151-3. PubMed ID: 8018528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Melphalan pharmacokinetics during isolated limb regional perfusion in patients with skin melanoma and soft tissue sarcoma].
    Gafton GI; Senchik KY; Petrov VG; V V Semiglazov ; N V Tatyanicheva ; V G Bespalov ; Semiletova YV; Gafton IG; Zinoviev GV; Kireeva GS
    Vopr Onkol; 2015; 61(6):932-6. PubMed ID: 26995981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melphalan concentration and distribution in the tissues of tumour-bearing limbs treated by isolated limb perfusion.
    Scott RN; Blackie R; Kerr DJ; Hughes J; Burnside G; MacKie RM; Byrne DS; McKay AJ
    Eur J Cancer; 1992; 28A(11):1811-3. PubMed ID: 1389515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of acute regional toxicity following isolated limb perfusion for melanoma.
    Thompson JF; Eksborg S; Kam PC; Ingvar C; Yau DF; Lai DT; Ramzan I
    Melanoma Res; 1996 Jun; 6(3):267-71. PubMed ID: 8819130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melphalan dosing regimens for management of recurrent melanoma by isolated limb perfusion: application of a physiological pharmacokinetic model based on melphalan distribution in the isolated perfused rat hindlimb.
    Wu ZY; Smithers BM; Roberts MS
    Melanoma Res; 1997 Jun; 7(3):252-64. PubMed ID: 9195565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of melphalan leakage during hyperthermic isolation perfusion in melanoma of the limb.
    Rauschecker HF; Foth H; Michaelis HC; Horst F; Gatzemeier W; Willenbrock C; Voth E; Kahl GF
    Cancer Chemother Pharmacol; 1991; 27(5):379-84. PubMed ID: 1998997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional perfusion treatment with melphalan for melanoma in a limb: an evaluation of drug kinetics.
    Benckhuijsen C; Kroon BB; van Geel AN; Wieberdink J
    Eur J Surg Oncol; 1988 Apr; 14(2):157-63. PubMed ID: 3360157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma.
    Minor DR; Allen RE; Alberts D; Peng YM; Tardelli G; Hutchinson J
    Cancer; 1985 Jun; 55(11):2638-44. PubMed ID: 3995475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melphalan uptake, hyperthermic synergism and drug resistance in a human cell culture model for the isolated limb perfusion of melanoma.
    Clark J; Grabs AJ; Parsons PG; Smithers BM; Addison RS; Roberts MS
    Melanoma Res; 1994 Dec; 4(6):365-70. PubMed ID: 7703715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2009 May; 16(5):1184-92. PubMed ID: 19224289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of human tumour and normal tissue pH during hyperthermic and normothermic antiblastic regional isolation perfusion for malignant melanoma: a pilot study.
    van de Merwe SA; van den Berg AP; Kroon BB; van den Berge AW; Klaase JM; van der Zee J
    Int J Hyperthermia; 1993; 9(2):205-17. PubMed ID: 8468505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of melphalan in isolated limb infusion for recurrent localized limb malignancy.
    Roberts MS; Wu ZY; Siebert GA; Anissimov YG; Thompson JF; Smithers BM
    Melanoma Res; 2001 Aug; 11(4):423-31. PubMed ID: 11479432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated limb perfusion with melphalan for human melanoma xenografts in the hindlimb of nude rats: a surviving animal model.
    Wu Z; Roberts MS; Parsons PG; Smithers BM
    Melanoma Res; 1997 Feb; 7(1):19-26. PubMed ID: 9067961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can tissue drug concentrations be monitored by microdialysis during or after isolated limb perfusion for melanoma treatment?
    Wu ZY; Smithers BM; Anderson C; Roberts MS
    Melanoma Res; 2000 Feb; 10(1):47-54. PubMed ID: 10711640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of isolated lower limb perfusion for loco-regional advanced/recurrent melanoma using borderline true hyperthermia plus additional bolus of melphalan. A critical analysis of homogeneous cases.
    Pace M; Gattai R; Mascitelli EM; Millanta L
    J Surg Oncol; 2011 Dec; 104(7):718-23. PubMed ID: 21721008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma.
    Scott RN; Kerr DJ; Blackie R; Hughes J; Burnside G; MacKie RM; Byrne DS; McKay AJ
    Br J Cancer; 1992 Jul; 66(1):159-66. PubMed ID: 1637666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity.
    Kam PC; Thompson JF
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1039-45. PubMed ID: 20604735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of dosimetric methods in isolated limb perfusion with melphalan for malignant melanoma of the lower extremity.
    Byrne DS; McKay AJ; Blackie R; MacKie RM
    Eur J Cancer; 1996 Nov; 32A(12):2082-7. PubMed ID: 9014749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient- and treatment-related factors associated with acute regional toxicity after isolated perfusion for melanoma of the extremities.
    Klaase JM; Kroon BB; van Geel BN; Eggermont AM; Franklin HR; Hart GA
    Am J Surg; 1994 Jun; 167(6):618-20. PubMed ID: 8209941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is melphalan dose adjustment according to ideal body weight useful in isolated limb infusion for melanoma?
    Huismans AM; Kroon HM; Haydu LE; Kam PC; Thompson JF
    Ann Surg Oncol; 2012 Sep; 19(9):3050-6. PubMed ID: 22526898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.